Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement - Medicus Pharma
Summary
Medicus Pharma entered into a warrant inducement agreement to accelerate the exercise of outstanding Series A and Series B warrants. The deal lowers the exercise price to $1.92 and is expected to bring in about $5.1 million in gross proceeds. In return, the company will issue new Series C and Series D warrants with a $2.00 exercise price. The transaction is expected to close on or about December 5, 2025, subject to customary conditions. Medicus Pharma describes itself as a biotech and life sciences company focused on clinical development of novel therapeutics.
Funding
Amount
$3.7M
Total raised
Date
December 5, 2025
Announcement date
Investors
-
Lead investors
Company
https://medicuspharma.com/
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected